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Summary
Objective: Dysregulated Wnt signaling appears to modulate chondrocyte fate and joint disorders. Dickkopf-1 (DKK1) regulates the pathogen-
esis of skeletal tissue by inhibiting Wnt actions. This study examined whether DKK1 expression is linked to chondrocyte fate in osteoarthritis
(OA).
Method: Articular cartilage specimens harvested from nine patients with knee OA and from six controls with femoral neck fracture were
assessed for DKK1, interleukin-1b (IL-1b), tumor necrosis factor-a (TNF-a), Bad, Bax, Bcl2 and caspase-3 expression by real time-polymerase
chain reaction (RT-PCR) and immunohistochemistry. Apoptotic chondrocytes were detected by terminal deoxynucleotidyl transferase-medi-
ated deoxyuridine triphosphate-biotin nick end-labelling (TUNEL) and 40, 6-dianidino-2-phenylindole dihydrochloride (DAPI) staining. Human
chondrocyte cultures were treated with recombinant IL-1b and monoclonal DKK1 antibody to determine whether DKK1 impairs chondrocyte
survival.
Results: Expression of DKK1 correlated with inﬂammatory cytokine levels (IL-1b and TNF-a expressions), proapoptosis regulators (Bad and
caspase-3 expressions) and TUNEL staining in OA cartilage tissues. The IL-1b induced expressions of DKK1, Bax, Bad and caspase-3-de-
pendent apoptosis of chondrocyte cultures. Neutralization of DKK1 by monoclonal DKK1 antibody signiﬁcantly abrogated IL-1b-mediated cas-
pase-3 cleavage and apoptosis and reversed chondrocyte proliferation. Recombinant DKK1 treatment impaired chondrocyte growth and
promoted apoptosis. By suppressing nuclear b-catenin accumulation and Akt phosphorylation, DKK1 mediated IL-1b promotion of chondro-
cyte apoptosis.
Conclusion: Chondrocyte apoptosis correlates with joint OA. Expression of DKK1 contributes to cartilage deterioration and is a potent factor in
OA pathogenesis. Attenuating DKK1 may reduce cartilage deterioration in OA.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA), a common cause of musculoskeletal
disability in developed countries1, is characterized by carti-
lage attrition, subchondral bone remodeling, osteophyte for-
mation and synovial inﬂammation. Cartilage deterioration
caused by inappropriate mechanical loading2, disturbed
biochemical regulation3 and genetic mutation4 is a potent
etiologic causes of OA.
Impaired chondrocyte survival in joint microenvironments
contributes to OA pathogenesis5. Perturbed homeostasis
caused by inﬂammation6, oxidative stress7, mitochondrial
dysfunction8 and proapoptotic/antiapoptotic dysregulation9
is known to modulate chondrocyte fate in the progression
of OA. However, the molecular mechanisms underlying the
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933Wnt/b-catenin signaling components are essential for
regulating cartilage development and the chondrocyte func-
tion10e12. Dysregulated Wnt proteins and destabilized
b-catenin signaling are known to modulate the pathogene-
sis of human joint disorders13. Perturbation of Wnt inhibitor
is reportedly a major contributor to osteoarthritic joint disor-
ders. Osteoarthritic tissue is known to display intense gene
expression and immunoreactivity of Wnt antagonists (se-
creted frizzled-related proteins; sFRPs)14,15. The sFRP3
gene mutations have also been linked to hip OA in
women16.
Secreted DKK1 suppresses the biological actions of Wnt
proteins17. ThisWnt inhibitor reportedlymodulates the devel-
opment and remodeling of various tissues. Dickkopf-1
(DKK1) is a potent osteogenesis-inhibiting factor that medi-
atesbone loss inducedbycancer cells, excessglucocorticoid
and estrogen depletion18e21. Increased DKK1 signaling
inhibits chondrogenesis in new bone formation22. Although
Wnt antagonist signaling is known to accelerate cartilage
deterioration, the biological role of DKK1 in chondrocyte
fate inOApathogenesis has not beenelucidated.Wehypoth-
esized that DKK1 signaling may affect OA pathogenesis.
934 L.-H. Weng et al.: DKK1 mediates chondrocyte apoptosisThis study investigated the spatial expression of DKK1
and inﬂammatory cytokines in the articular cartilage of pa-
tients with and without OA and examined whether DKK1 ex-
pression is linked to inﬂammatory cytokine induction of
chondrocyte apoptosis.
Materials and methodsPATIENTSThis study was approved by the Institutional Review Board of this hospi-
tal, and informed consent was obtained from all subjects. The articular knee
cartilage specimens were obtained from nine patients (all female; 70.9 9.0
years old) with end-stage OA requiring total joint arthroplasty. Biopsy was
performed on articular cartilage specimens from the hips of six femoral
neck fracture patients who had undergone bipolar hip replacement (ﬁve
females and one male; 68.8 10.8 years old). Primary chondrocyte cultures
were obtained from articular cartilage from three knee OA patients who had
undergone arthroplasty (all female; 65, 67 and 75 years old) and from two
female patients with femoral neck fracture (64 and 79 years old).PRIMARY CHONDROCYTE CULTURESUnder aseptic conditions, cartilage specimens were sliced, minced, and
incubated in 0.05% trypsin (SigmaeAldrich Inc., St. Louis, MO) for 25 min
at room temperature. The cartilage fragments were further incubated in car-
tilage dissecting medium (Ham’s F12, 4 mg/ml G418, 10 mg/ml vancomycin
and 30 mg/ml ceftazidim; SigmaeAldrich Inc.) containing 0.3% collagenase
(SigmaeAldrich Inc.) for 30 min then incubated in cartilage dissecting
medium containing 0.06% collagenase at 37C for 16 h. After ﬁltering the
mixtures through a 70-mm ﬁlter, the cells were re-suspended in growth
medium (Dulbecco’s modiﬁed Eagle’s medium (DMEM) and Ham’s F12,
10% fetal bovine serum, 4 mg/ml G418) until subconﬂuent. The ﬁrst two pas-
sages of cell cultures were used for subsequent experiments.REAL TIME-POLYMERASE CHAIN REACTION (RT-PCR)Tissues were ground with pestle and mortar in liquid nitrogen under
RNase-free conditions. Total RNA from tissues and cell cultures was
extracted with Tri reagent containing monophasic solution of guanidine thio-
cyanate and phenol (SigmaeAldrich Inc.); 1 mg total RNA was reverse-
transcribed at 50C for 2 min and then at 60C for 30 min. Template (equivalent
20 ng total RNA) was ampliﬁed at 95C for 5 min followed by 40 cycles of
PCR reaction at 94C for 20 s and 60C for 1 min using 2X iQ SYBR Green
Supermix and the iCycler iQ Real-time PCR Detection System (Bio-Rad
Laboratories, Hercules, CA). The following gene-speciﬁc primers were
used: DKK1 (forward, 50-GAG TCC TTC TGA GAT GAT GG-30; reverse,
50-TTG ATA GCG TTG GAA TTG AG-30; 141-base pair expected); interleu-
kin-1b (IL-1b) (forward, 50-ACG ATG CAC CTG TAC GAT CA-30; reverse,
50-TCT TTC AAC ACG CAG GAC AG-30; 226-base pair expected); tumor
necrosis factor-a (TNF-a) (forward, 50-TCC TTC AGA CAC CCT CAA CC-
30; reverse, 50-CAG GGA TCA AAG CTG TAG GC-30; 208-base pair ex-
pected); Bad (forward, 50-CCG AGT GAG CAG GAA GA CTC-30; reverse,
50-GGT AGG AGC TGT GGC GAC T-30; 205-base pair expected); Bax (for-
ward, 50-GCT GGA CATTGG ACT TCC TC-30; reverse, 50-CAC TGT GAC
CTG CTC CAG AA-30; 181-base pair expected); caspase-3 (forward, 50-
TGG AAT TGA TGC GTG ATG TT-30; reverse, 50-GGC AGG CCT GAA
TAA TGA AA-30; 203-base pair expected); Bcl2 (forward, 5´-TTG TTC AAA
CGG GAT TCA CA-30; reverse, 50-GAG CAA GTG CAG CCA CAA TA-30;
176-base pair expected) and 18S rRNA (forward, 50-GTA ACC CGT TGA
ACC CCA TT-30; reverse, 50-CCA TCC AAT CGG TAG TAG CG-30; 153-
base pair expected). The arbitrary intensity threshold (Ct) of ampliﬁcation
was also computed. Relative expression level was deﬁned as 2(DCt),
where DCt¼Cttarget geneCt18S. In cell culture experiments, the fold change
in mRNA expression was deﬁned as 2DDCt, where DDCt¼DCttreatment
DCtvehicle.IMMUNOHISTOCHEMISTRYSpecimens were ﬁxed in 4% PBS-buffered formaldehyde, decalciﬁed in
10% phosphate-buffered saline (PBS-buffered) ethylenediaminetetraacetic
acid (EDTA), embedded in parafﬁn, longitudinally cut into 5-mm sections
and then transferred onto poly-lysine-coated slides. Immunoreacitivity was
then tested by respective antibodies against DKK1, IL-1b, TNF-a (Santa
Cruz Biotechnology Inc., Santa Cruz, CA) and cleaved caspase-3 (Cell Sig-
naling Technology Inc., Beverly, MA) using a non-biotin horseradish perox-
idase detection system (BioGenex Laboratories Inc., San Ramon, CA)
followed by counterstained with hematoxylin, dehydration and mounting.
Those without primary antibodies were enrolled as negative controls forthe immunostaining. Ten images were randomly selected from two sections
of each specimen and the stained cells were counted under 400 magni-
ﬁcation using a Zeiss Axioskop 2 plus microscope (Carl Zeiss Microimaging
Inc., Gottigen, Germany) with a cool charge-coupled device camera and
the Image-Pro Plus image analysis software (SNAP-Pro cf. Digital kit; Me-
dia Cybernetics Inc., Silver Spring, MD). The positive immunolabeled and
total cells per high power ﬁeld in each section were counted, and the per-
centage of positive labeled cells was calculated.CELL APOPTOSISTerminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine tri-
phosphate-biotin nick end-labelling (TUNEL) was performed to detect apo-
ptotic cells in the cartilage specimens by In Situ Cell Apoptosis Detection
kits (Roche Diagnostics, East Sussex, UK) according to the manufacturer in-
structions. Brieﬂy, deparafﬁnized sections were permeabilized using 0.1%
Triton-X 100 for 20 min. Sections were probed with reaction buffer containing
ﬂuorescein-labeled deoxyuridine triphosphate (dUTP) and TdT for 60 min
then incubated with ﬂuorescein antibody conjugated with alkaline phospha-
tase for 30 min. After PBS rinsing, sections were subsequently developed
with substrate solution containing fast red. Sections without primary TdT
were designated as negative controls. Ten images were randomly selected
from two sections of each specimen and the stained cells were counted un-
der 400 magniﬁcation. In cell culture experiments, cultured chondrocytes
were stained with 40,6-dianidino-2-phenylindole dihydrochloride (DAPI;
2 mg/ml, SigmaeAldrich Inc.) at 37C for 30 min. Apoptotic cells exhibiting
condensed or fragmented chromatin were recognized with dual TUNEL
and DAPI staining. For each group in three repeated experiments, nine im-
ages were randomly selected under 200 magniﬁcation using an Axiovert
200 inverted ﬂuorescence microscope. An Axiocam HRM cool charge-
coupled device camera and an Axio Vision 4 image-analysis software
(Carl Zeiss, Gottingen, Germany) were used for imaging. The apoptotic cells
and total cells were counted, and the percentage of dual stained cells in each
image was calculated.CELL CULTURESPrimary human chondroyctes were cultured in DMEM/Ham’s F12 (1:1,
v/v) with 10% fetal bovine serum and 4 mg/ml G418. Human fetal chondro-
cytes (CRL-2847; American Type Culture Collection, Manassas, VA) were
cultured in DMEM with 10% fetal bovine serum and 0.1 mg/ml G418 in
a 5% CO2, 37
C incubator until 80% conﬂuent. Cells (1 105 cells/well,
6-well plate) were treated with recombinant human IL-1b (5, 10 and 15 ng/
ml; R & D Systems Inc., Minneapolis, MN) and recombinant human DKK1
(100, 200 and 400 ng/ml; R & D Systems Inc.) for 12 h, 24 h, and 48 h. In
some experiments, cell cultures were pretreated with 10 mM caspase-3 inhib-
itor (Z-DEVD-FMK; Calbiochem, Darmstadt, Germany) and neutralized with
10 mg/ml DKK1 monoclonal antibody (R & D Systems Inc.) and 10 mg/ml
human IgG (CSL Ltd., Parkville, Australia) and then treated with 10 ng/ml
IL-1b or 400 ng/ml DKK1. To investigate cell apoptosis, suspended and
adhesive cells were pooled onto poly-lysine pre-coated glass slides then
ﬁxed with ice-cold methanol and then subjected to morphological
observation and TUNEL staining.CELL GROWTHCell proliferation was determined by Cell Proliferation Assay Kits (Roche
Diagnostics, Mannheim, Germany) according to the manufacturer instruc-
tions. Brieﬂy, cells (1 104 cells/well, 96-well plate) with and without IL-1b
and DKK1 treatments were cultured for 48 h. Aliquots of 3-(4,5-dimethylthia-
zol-2yl)2,5-diphenyltetrazolium bromide were then added to each well. For-
mazan synthesized by the cultured cells was dissolved by 100 ml of 10%
SDSe0.01 M HCl and the absorbance of the mixtures was colorimetrically
measured at 550 nm (Amersham Biosciences Buckinghamshire, UK).IMMUNOBLOTTINGCytosolic and nuclear fractions of cell lysates were prepared for immuno-
blotting as previously described23. The designated proteins on the blots were
probed by primary antibodies against caspase-3, cleaved caspase-3,
cleaved poly (ADP-ribose) polymerase (PARP), b-catenin, phosphorylated-
Ser473-Akt and actin (Cell Signaling Technology Inc., Beverly, MA) followed
by horseradish peroxidase-conjugated IgG as the secondary antibody then
visualized with chemiluminescence agents. For each blot in three repeated
experiments, protein band intensity was quantiﬁed by scanning
densitometry.STATISTICAL ANALYSISAll values were expressed as means standard deviations. The Wil-
coxon test was used to evaluate differences between the clinical samples
935Osteoarthritis and Cartilage Vol. 17, No. 7of interest and their respective controls. In vitro experimental data were col-
lected from at least three repeated experiments. Analysis of variance (AN-
OVA) was performed to evaluate differences between the samples of
interest and their respective controls, and the Scheffe test was used for pos-
terior comparison. The histological data were analyzed by general linear
model followed by partial correlation test to determine the signiﬁcant differ-
ences between treatments. A P-value of <0.05 was considered statistically
signiﬁcant.ResultsPROMOTION OF INFLAMMATION AND APOPTOSIS
IN OA CARTILAGESThe two groups did not signiﬁcantly differ in age
(P¼ 0.353) or gender (P¼ 0.102). Real time RT-PCR re-
sults revealed signiﬁcantly increased expressions of IL-1b
[P¼ 0.0491; Fig. 1(A)], TNF-a [P¼ 0.0085; Fig. 1(B)], proa-
poptosis regulators Bad [P¼ 0.004; Fig. 1(C)], Bax
[P¼ 0.0266; Fig. 1(D)] and caspase-3 mRNA [P¼ 0.008;
Fig. 1(E)] in OA patients. However, expression of anti-apo-
ptosis modulator Bcl2 mRNA was signiﬁcantly lower in OA
patients [P< 0.0001; Fig. 1(F)]. These ﬁndings indicate
the inﬂammatory and apoptotic activities in OA cartilages.Fig. 1. Articular cartilage specimens from osteoarthritic joints had higher
and (E) caspase-3 and lower mRNA expression of (F) Bcl2 than those fr
alyzed by real time RT-PCR. The relative abundance of the targeted gen
presented as 2(DCt), where DASSOCIATION OF DKK1 WITH INFLAMMATION AND
APOPTOSIS IN OA CARTILAGESExpression of DKK1 was examined for associations with
OA. Quantitative RT-PCR results showed that OA carti-
lages had higher DKK1 mRNA expression than controls
[P¼ 0.0396; Fig. 2(A)]. Moreover, DKK1 mRNA expression
signiﬁcantly correlated with expression of IL-1b [r¼ 0.9993,
P< 0.0001; Fig. 2(B)], TNF-a [r¼ 0.7365, P¼ 0.037;
Fig. 2(B)], Bad [r¼ 0.9569, P< 0.0001; Fig. 2(C)], and
caspase-3 mRNA [r¼ 0.7502, P¼ 0.031; Fig. 2(D)].INCREASED DKK1 EXPRESSION CORRELATES WITH
CHONDROCYTE INFLAMMATION AND APOPTOSISImmunohistochemistry was examined in inﬂammatory cy-
tokines, DKK1, cleaved caspase-3 and TUNEL staining in
cartilage microenvironments. Cells with positive IL-1b,
TNF-a and DKK1 displayed brown staining in the periphery
and cytoplasm. Cells with positive cleaved caspase-3
expression and TUNEL staining displayed brown and red
staining in the nucleus. Chondrocytes in OA cartilage
exhibited intense DKK1, IL-1b, TNF-a, cleaved caspase-3mRNA expression levels of (A) IL-1b, (B) TNF-a, (C) Bad, (D) Bax,
om femoral neck fracture patients. The mRNA expression was an-
e was normalized to that of the housekeeping gene 18S and was
Ct¼Cttarget geneCt18S.
Fig. 2. The articular cartilage harvested from patients with osteoarthritic joint exhibited higher levels of (A) DKK1 mRNA expression than that
harvested from patients with femoral neck fractures. The mRNA expression was analyzed by real time RT-PCR. The relative abundance of the
targeted gene was normalized to that of the housekeeping gene 18S. Increased DKK1 mRNA expression was correlated with increased
mRNA expression of (B) IL-1b and TNF-a, (C) Bad and (D) caspase-3 in the articular cartilage of OA patients.
936 L.-H. Weng et al.: DKK1 mediates chondrocyte apoptosisexpressions and TUNEL staining [Fig. 3(A)]. Chondral cells
in the control group displayed weak expressions of DKK1,
IL-1b, TNF-a, cleaved caspase-3 and TUNEL staining
[Fig. 3(A)]. Histomorphometric analyses showed that OA
patients had signiﬁcantly higher DKK1 expression associ-
ated with intense IL-1b, cleaved caspase-3, TNF-a immuno-
reactivity and TUNEL staining in chondrocytes [Fig. 3(B)].
The DKK1 immunostaining signiﬁcantly correlated with
IL-1b (r¼ 0.468, P< 0.0001), TNF-a (r¼ 0.7201,
P< 0.0001), cleaved caspase-3 expression (r¼ 0.7216,
P< 0.0001), and TUNEL staining (r¼ 0.9983, P< 0.0001).DKK1 MEDIATES IL-1b INDUCTION OF APOPTOSIS PROGRAMS
IN HUMAN FETAL CHONDROCYTESFurther experiments investigated whether DKK1 partici-
pates in inﬂammatory cytokine induction of chondrocyte
apoptosis. Human fetal chondrocyte cultures were treated
with recombinant human IL-1b. The IL-1b dose-dependently
increased the number of apoptotic cells [Fig. 4(A)] and the
expression of DKK1 mRNA in cell cultures [Fig. 4(B)]. Of
the varying recombinant IL-1b concentrations, the 10 ng/ml
IL-1b dose produced the greatest chondrocyte apoptosis
and was used in subsequent experiments. Recombinant
human DKK1 treatment increased chondrocyte apoptosis.
The 400 ng/ml DKK1 treatment was the most potent treat-
ment for promoting chondrocyte apoptosis and was used
in the following experiments [Fig. 4(C)]. The DKK1 treat-
ment time-dependently increased chondrocyte apoptosis
[Fig. 4(D)]. Fluorescence microscopy revealed chondro-
cytes with fragmented chromatin by TUNEL staining (green
ﬂuorescence) and DAPI staining (blue ﬂuorescence) in the
nucleus. In both IL-1b and DKK1 groups, chondrocytes dis-
played intense fragmented chromatin formation. Few cellsin the control group displayed fragmented chromatin
[Fig. 4(E)].
Quantitative RT-PCR results indicated that IL-1b signiﬁ-
cantly promoted Bad [Fig. 5(A)], Bax [Fig. 5(B)] and cas-
pase-3 mRNA expression [Fig. 5(C)], but inhibited Bcl2
mRNA expression [Fig. 5(D)]. However, the regulatory ef-
fects could be suppressed by DKK1 monoclonal antibody
neutralization. Recombinant DKK1 treatment signiﬁcantly
promoted Bad, Bax and caspase-3 mRNA expression but
reduced Bcl2 expression. Immunoglobulin treatment did
not signiﬁcantly alter the regulatory effects of IL-1b on
Bad, Bax, caspase-3 or Bcl2 mRNA expression (Fig. 5).
Moreover, IL-1b and DKK-1 treatment increased cleaved
caspase-3 (corresponding to 17 kDa) and cleaved PARP
(corresponding to 89 kDa) expressions [Fig. 6(A)], pro-
moted cell apoptosis [Fig. 6(B)] and attenuated cell culture
growth [Fig. 6(C)]. Caspase-3 inhibitor Z-DEVD-FMK treat-
ment abrogated IL-1b- and DKK1-mediated caspase-3 and
PARP cleavage but increased chondrocyte survival. DKK1
antibody neutralization moderated IL-1b-induced apoptosis
as well as promoted cell proliferation. Immunoglobulin treat-
ment did not signiﬁcantly alter IL-1b-induced apoptotic
activity in cell cultures (Fig. 6).DKK1 MODULATES Akt AND b-CATENIN SIGNALINGImmunoblotting revealed that IL-1b treatment attenuated
expressions of phosphorylated-Ser473-Akt and nuclear
b-catenin in the chondrocyte cultures (Fig. 7). The DKK1
antibody neutralization increased nuclear b-catenin accumu-
lation and phosphorylated Akt expression of chondrocytes
exposed to IL-1b stress. Recombinant DKK1 treatment re-
duced nuclear b-catenin accumulation and Akt phosphory-
lation of chondrocyte cultures (Fig. 7).
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Fig. 3. Representative immunohistochemical photographs of (A) DKK1, IL-1b, TNF-a, cleaved caspase-3 and TUNEL staining in osteoarthritic
cartilages and control samples. Chondrocytes in OA cartilages displayed intense expressions of DKK1, IL-1b, TNF-a and cleaved csapase-3
as well as TUNEL staining (arrows). (B) Histomorphometric analyses showed that OA patients had signiﬁcantly higher DKK1, IL-1b, TNF-a,
and cleaved caspase-3 expressions and TUNEL staining in chondrocytes. The ‘‘*’’ indicates differences between the OA and control groups,
P< 0.05.
937Osteoarthritis and Cartilage Vol. 17, No. 7DKK1 MEDIATES IL-1b-INDUCED APOPTOSIS IN EX VIVO
CHONDROCYTES FROM ADULT SUBJECTSFurther experiments investigated whether IL-1b or DKK1
induces apoptosis of primary human chondrocytes har-
vested from the three OA joint cartilage of adult subjects.
The IL-1b and DKK1 treatments signiﬁcantly increased
mRNA expressions of Bad [Fig. 8(A)], Bax [Fig. 8(B)], cas-
pase-3 [Fig. 8(C)] and apoptotic cell number in primary chon-
drocytes [Fig. 8(E)]. The IL-1b and DKK1 treatments
signiﬁcantly inhibited Bcl2 mRNA expression [Fig. 8(D)]
and cell culture proliferation [Fig. 8(F)]. DKK1 monoclonal
antibody neutralization and Z-DEVD-FMK treatment signiﬁ-
cantly abrogated apoptotic activity and reversed the growth
of IL-1b- and DKK1-stressed primary chondrocyte cultures
(Fig. 8). Caspase-3 inhibitor Z-DEVD-FMK abrogated IL-
1b- and DKK1-mediated suppression of primary human
chondrocytes survival [Fig. 8(E)] and cell proliferation[Fig. 8(F)]. Immunoglobulin treatment did not signiﬁcantly
alter apoptosis programs in IL-1b-stressed primary human
chondrocyte cultures. TUNEL and DAPI staining revealed
that cells displayed intense fragmented chromatin formation
in IL-1b and DKK1 groups. Few chondrocytes displayed
fragmented chromatin in the DKK1 antibody neutralization
and caspase-3 inhibitor-treated groups (Fig. 9). Recombi-
nant IL-1b and DKK1 also promoted apoptosis of chondro-
cytes isolated from joint cartilage in fracture femoral neck.
Caspase-3 inhibitor pretreatment and DKK1 antibody neu-
tralization attenuated the promoting effects of IL-1b and
DKK1 on chondrocyte apoptosis (Supplementary data).
Discussion
UpregulatedDKK1expressioncorrelatedwith increased in-
ﬂammatory cytokine expression in OA joints. This Wnt
Fig. 4. Effects of recombinant human IL-1b and DKK1 treatments on apoptosis and DKK1 expression of chondrocyte cultures. The IL-1b treat-
ment dose-dependently increased (A) the number of apoptotic cells and (B) DKK1 mRNA expression in chondrocyte cultures. (B) Recombi-
nant human DKK1 treatment (C) dose- and (D) time-dependently increased the number of apoptotic chondrocytes. (E) Representative
ﬂuorescence staining of apoptotic chondrocytes. Fragmented chromatin in cell cultures was detected by TUNEL (green ﬂuorescence) and
DAPI (blue ﬂuorescence) staining. Human fetal chondrocytes (1 105 cells/well; 6-well plate) with and without recombinant IL-1b and
DKK1 treatments were cultured in DMEM with 10% fetal bovine serum for 48 h. The mRNA expressions were measured by quantitative
RT-PCR and normalized to the housekeeping gene 18S. The ‘‘*’’ indicates differences between the vehicle-treated, IL-1b-treated and
DKK1-treated groups, P< 0.05.
938 L.-H. Weng et al.: DKK1 mediates chondrocyte apoptosisinhibitor was linked to promotion of chondrocyte apoptosis in
the OA cartilage. Growing evidence indicates that the Wnt
pathway regulates cartilage integrity and joint develop-
ment24e26 and that upregulated Wnt antagonism action is
linked to the pathogenesis of joint disorders15,27. However,
the pathogenic role of the Wnt inhibitor DKK1 in the fate of
chondral cells in OA joints has seldom been addressed. The
current ﬁndings are, to our knowledge, the ﬁrst indication
that DKK1 mediates inﬂammatory cytokine suppression of
Akt activation andnuclear b-catenin accumulation andsubse-
quently induces chondrocyte apoptosis. These ﬁndingssuggest thatDKK1-mediated proapoptotic activity in chondro-
cytes contributes to osteoarthritic joint formation. Inﬂamma-
tion disturbance of DKK1/b-catenin signaling in
chondrocytes provides a new molecular insight into the path-
ogenesis of diminished cartilage integrity associatedwith OA.
Chondrocytes in the OA cartilage intensely expressed
IL-1b and TNF-a associated with OA. The mechanisms
underlying intense inﬂammatory cytokine expression in
OA joint microenvironments are unclear. Increased carti-
lage inﬂammation impairs extracellular matrix accumulation
of chondral cells during the pathogenesis of joint disorders,
Fig. 5. Effects of recombinant IL-1b and DKK1 treatments on apoptotic activity of chondrocyte cultures. The IL-1b treatment increased (A) Bad,
(B) Bax and (C) caspase-3 mRNA expressions but inhibited (D) Bcl2 mRNA expression of cell cultures, which was abrogated by DKK1 mono-
clonal antibody neutralization. Recombinant DKK1 treatment signiﬁcantly regulated proapoptosis and anti-apoptosis gene expression in chon-
drocytes. Human fetal chondrocytes (1 105 cells/well; 6-well plate) with and without recombinant 10 ng/ml IL-1b, 400 ng/ml DKK1, 10 mg/ml
DKK1 monoclonal antibody and 10 mg/ml immunoglobulin treatments were cultured in DMEM with 10% fetal bovine serum for 48 h. The mRNA
expressions were measured by quantitative RT-PCR and normalized to the housekeeping gene 18S and presented as 2DDCt. The ‘‘*’’ and ‘‘#’’
indicate differences between the vehicle-treated, IL-1b-treated and DKK1-treated groups, respectively, P< 0.05.
939Osteoarthritis and Cartilage Vol. 17, No. 7apparently as a biological reaction to deteriorating cartilage
function6,28. In the current study, promotion of proapoptosis
regulators Bad, Bax and caspase-3 expressions as well as
attenuation of anti-apoptosis modulator Bcl2 expression
and chondrocyte apoptosis coincided with increased
inﬂammatory cytokine expression in OA cartilage, suggest-
ing that inﬂammation-mediated chondrocyte apoptosis con-
tributes to the disruption of cartilage integrity. These
ﬁndings agree with previous studies that demonstrate the
upregulation of IL-1b expression in OA articular cartilage29.
Diminished chondrocyte survival due to inﬂammation is
a proposed pathogenic cause of OA. Previous studies
demonstrate that Bcl2 expression is higher in advanced
OA lesions than in non-OA sites or in sites with minimal
OA damage30. However, articular cartilage in normal
subjects is known to have higher Bcl2 immunostaining
than that in OA patients31. The Bcl2 gene expression in
advanced OA cartilage is lower than that in cartilage with
minimal OA damage32. The current study revealed
reduced Bcl2 mRNA expression in cartilage tissue har-
vested from patients with end-stage OA. We speculate
that cartilage with varying severity of OA differ in Bcl2
expression.
WhileWnt antagonist sFRP is known to inhibit chondrocyte
differentiation and growth, growing evidence demonstrates
that reactive oxygen radicals, endothelin-1, glucocorticoids,
tau and thalidomide participate in DKK1-mediated tissue re-
modeling and tumoriogenesis33e37 and that DKK1 inhibitsthyroid hormone-mediated chondrocyte differentiation of
growth plate38. However, the biological role of DKK1 in the
development of OA has not been characterized. This study
provides novel evidence that increased DKK1 expression
correlates with inﬂammatory cytokine expression and chon-
drocyte apoptosis in OA cartilage. The DKK1 is a potent ap-
optosis-promoting factor in modulating the development of
skeletal tissue and several cell types39e41. Moreover, chon-
drocyte cultures respond to IL-1b stress by increasing
DKK1 expression and apoptosis programs. The phenomena
observed in the in vitromodel were consistent with those de-
tected in both in vivo and ex vivo primary chondrocyte cul-
tures. We suggest that, in OA pathogenesis, DKK1 is at
least one proapoptotic factor that mediates inﬂammatory cy-
tokine-induced caspase-3-dependent chondral cell apopto-
sis. This is based on the observation that DKK1 antibody
neutralization abrogates the promoting effect of IL-1b on
proapoptotic geneexpression and in vitro programmed death
of chondrocytes. Recombinant DKK1 treatment alone in-
creases apoptosis in chondrocyte cultures. To our knowl-
edge, this is the ﬁrst report that disturbed DKK1 expression
modulates inﬂammation induction of chondrocyte apoptosis
in OA articular cartilage.
The IL-1b treatment attenuated Akt phosphorylation and
nuclear b-catenin accumulation but was abrogated by
DKK1 monoclonal antibody neutralization. The role of b-cat-
enin signaling in controlling chondrocyte function and carti-
lage structure is controversial. The b-catenin signaling is
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Fig. 6. Effects of IL-1b and DKK1 on chondrocyte survival. The IL-1b and DKK1 treatments (A) increased cleaved caspase-3 and cleaved
PARP expressions, (B) promoted apoptotic cell number and (C) inhibited chondrocyte growth. Caspase-3 inhibitor and DKK1 monoclonal
antibody neutralization attenuated cleaved caspase-3 and cleaved PARP expressions and increased survival of cell cultures. Human fetal
chondrocytes (1 105 cells/well; 6-well plate) with and without recombinant 10 ng/ml IL-1b, 400 ng/ml DKK1, 10 mg/ml DKK1 monoclonal an-
tibody, 10 mg/ml immunoglobulin and 10 mM caspase-3 inhibitor Z-DEVD-FMK treatments were cultured in DMEM with 10% fetal bovine serum
for 48 h. The ‘‘*’’ and ‘‘#’’ indicate differences between the vehicle-treated, IL-1b-treated and DKK1-treated groups, respectively, P< 0.05.
940 L.-H. Weng et al.: DKK1 mediates chondrocyte apoptosisreportedly an essential Wnt signaling component for regu-
lating chondrogenic cell growth42 and osteogenic cell sur-
vival43. Increased b-catenin suppresses chondrocyte
differentiation44 and is associated with the IL-1b-mediatedp-Akt
β-catenin
Actin
IL1β - + - + +
rDKK1 - - + - - 
DKK1 mAb - - - + - 
IgG - - - - +
Fig. 7. Representative immunoblotting of nuclear b-catenin and phospho
nant DKK1 stresses, DKK1 antibody neutralization and immunoglobulin G
ylated-Ser473-Akt expression. Recombinant DKK1 treatment reduced
expression in chondrocyte cultures. DKK1 antibody neutralization abro
Ser473-Akt expressions of chondrocytes. Actin on the blots showed equ
ences between the vehicle-treated, IL-1b-treated andde-differentiation of arthritic chondrocytes45. The DKK1 dis-
turbs b-catenin signaling-dependent tissue regeneration
activity46. In this study, recombinant DKK1 inhibited nuclear
b-catenin accumulation and Akt phosphorylation, 
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rylated-Ser473-Akt in chondrocytes exposed to IL-1b and recombi-
. The IL-1b inhibited nuclear b-catenin accumulation and phosphor-
nuclear b-catenin accumulation and phosphorylated-Ser473-Akt
gated IL-1b-suppression of nuclear b-catenin and phsphorylated-
al loading and transfer for all lanes. The ‘‘*’’ and ‘‘#’’ indicate differ-
DKK1-treated groups, respectively, P< 0.05.
Fig. 8. Effects of IL-1b and DKK1 treatments on apoptosis in ex vivo primary human chondrocyte cultures. The IL-1b and DKK1 treatments
increased (A) Bad, (B) Bax and (C) caspase-3 mRNA expressions and (E) apoptotic cell number. The IL-1b and DKK1 treatments inhibited (D)
Bcl2 mRNA expression and (F) chondrocyte proliferation. DKK1 monoclonal antibody neutralization and caspase-3 inhibitor attenuated apo-
ptosis activity and increased growth of IL-1b- and DKK1-treated chondrocytes. Primary human chondrocyte cultures were harvested from OA
knee cartilage in adult subjects. Cells (1 105 cells/well; 6-well plate) with and without recombinant 10 ng/ml IL-1b, 400 ng/ml DKK1, 10 mg/ml
DKK1 monoclonal antibody, 10 mg/ml immunoglobulin and 10 mM caspase-3 inhibitor Z-DEVD-FMK treatments were cultured in DMEM/Ham’s
F12 with 10% fetal bovine serum for 48 h. The mRNA expressions were measured by quantitative RT-PCR and normalized to the housekeep-
ing gene 18S and presented as 2DDCt. The ‘‘*’’ and ‘‘#’’ indicate differences between the vehicle-treated, IL-1b-treated and DKK1-treated
groups, respectively, P< 0.05.
941Osteoarthritis and Cartilage Vol. 17, No. 7suggesting that b-catenin and Akt are essential for chondro-
cytes survival after exposed to IL-1b and DKK1 stress.
Previous studies indicate that IL-1b treatment does not
induce apoptosis in immortalized human juvenile chondro-
cytes47 and normal human articular chondrocytes48. IL-1b
and TNF-a co-treated with actionmycin D6, oxygen radical
scavenger49 and kinase inhibitors50 induce apoptosis of
human chondrocyte cultures from OA cartilage. The current
study demonstrated that IL-1b promotes expression of proa-
poptosis regulators as well as apoptosis of human fetal
chondrocyte cultures and primary chondrocytes in cartilage
harvested from adult subjects. The results of this study
agree previous reports that IL-1b suppresses viability andFig. 9. Representative ﬂuorescence staining of apoptotic primary human c
TUNEL (green ﬂuorescence) and DAPI (blue ﬂuorescence) staining. The I
were alleviated by DKK1 monoclonal antibody neutralization and capase
increased chondrocinduces apoptotic signaling in human chondrocytes
harvested from articular cartilage51,52 and OA cartilage53,54.
In this study, the observation of increased expression of
apoptosis-promoting factor DKK1, caspase-3 and PARP
cleavage and suppression of anti-apoptosis regulator and
cell proliferation also support the debilitating effect of IL-1b
on chondrocyte cultures. We speculate that the discrepant
deleterious effects of IL-1b on chondrocyte apoptosis may
be due to varying concentration and duration of IL-1b
treatment.
In addition to cartilage degradation, synovitis and sub-
chondral bone destruction with excess remodeling, sclero-
sis and osteophytes reportedly contribute to OAhondrocytes. Fragmented chromatin in cell cultures was detected by
L-1b and DKK1 treatments promoted chondrocyte apoptosis, which
-3 inhibitor Z-DEVD-FMK treatment. Recombinant DKK1 treatment
yte apoptosis.
942 L.-H. Weng et al.: DKK1 mediates chondrocyte apoptosispathogenesis55. The ﬁndings of this study do not exclude
the possibility that DKK1 alters the cell fate or deteriorates
the microstructures of these tissues. Inﬂammatory cyto-
kines may directly or indirectly alter DKK1 expression. An
acknowledged limitation of this study is that the articular
cartilage specimens were not compared with those from
healthy subjects. However, our observations conﬁrm the
correlation between increased DKK1 expression and the
incidence of joint OA. This study provides novel evidence
of a pathomechanism in which Wnt inhibitor DKK1 has
a potent cartilage-deleterious role in the pathogenesis of
OA. Further studies may examine whether attenuating
DKK1 action prevents cartilage deterioration in OA.
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